Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

The Effect of Prucalopride on the Plasma Levels of Oral Contraceptives (Ethinylestradiol and Norethisterone) in Healthy Subjects.

Next Previous
Trial Profile

The Effect of Prucalopride on the Plasma Levels of Oral Contraceptives (Ethinylestradiol and Norethisterone) in Healthy Subjects.

Status: Completed
Phase of Trial: Phase I

Latest Information Update: 11 Aug 2013

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Prucalopride (Primary) ; Ethinylestradiol/norethisterone
  • Indications Constipation; Menopausal syndrome; Pregnancy
  • Focus Pharmacokinetics
  • Sponsors Shire-Movetis NV

Most Recent Events

  • 26 Aug 2010 According to a Movetis media release, data from this study were used as part of the EMA post-marketing commitments made by Movetis at the time of the drug's European approval in May 2010.
  • 08 Jun 2010 Status changed from not yet recruiting to completed as reported by ClinicalTrials.gov.
  • 08 Jun 2010 Actual initiation date (Dec 2009) added as reported by ClinicalTrials.gov.

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top